GOEL AJAY has a total of 11 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, medical technology and pharmaceuticals are LEICA BIOSYSTEMS NEWCASTLE LTD, SYNERGENZ BIOSCIENCE LTD and JUNEAU BIOSCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | United Kingdom | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Pharmaceuticals | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Diagnosis and surgery | |
#4 | Fermentation | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Boland C Richard | 9 |
#2 | Goel Ajay | 9 |
#3 | Hur Keun | 4 |
#4 | Balaguer Francesc | 3 |
#5 | Toiyama Yuji | 2 |
#6 | Salvatella Juan Jose Lozano | 1 |
#7 | Link Alexander | 1 |
#8 | Nagasaka Takeshi | 1 |
#9 | Ruiz Leticia Moreira | 1 |
#10 | Gironella I Cos Meritxell | 1 |
Publication | Filing date | Title |
---|---|---|
GB201902546D0 | A portion control food device | |
GB201803148D0 | A portion control food device | |
WO2014145612A1 | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer | |
US2012295267A1 | Detecting DNA Mismatch Repair-Deficient Colorectal Cancers |